149 related articles for article (PubMed ID: 16009076)
21. Prevalence of problematic and injecting drug use for Drug Action Team areas in England.
Frisher M; Heatlie H; Hickman M
J Public Health (Oxf); 2006 Mar; 28(1):3-9. PubMed ID: 16436448
[TBL] [Abstract][Full Text] [Related]
22. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
23. Estimating chronic disease prevalence among the remote Aboriginal population of the Northern Territory using multiple data sources.
Zhao Y; Connors C; Wright J; Guthridge S; Bailie R
Aust N Z J Public Health; 2008 Aug; 32(4):307-13. PubMed ID: 18782390
[TBL] [Abstract][Full Text] [Related]
24. [Prehospital treatment of patients with opiate overdose in Copenhagen 1995-1998].
Ishøy T; Høgskilde SA; Haastrup L
Ugeskr Laeger; 2003 Sep; 165(38):3624-7. PubMed ID: 14556395
[No Abstract] [Full Text] [Related]
25. Estimation of non-fatal road traffic injuries in Thai Nguyen, Vietnam using capture-recapture method.
Van HT; Singhasivanon P; Kaewkungwal J; Suriyawongpaisal P; Khai LH
Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):405-11. PubMed ID: 17125007
[TBL] [Abstract][Full Text] [Related]
26. Estimating the prevalence of individuals likely to use publicly funded alcohol treatment services: an indirect estimation technique.
Clemens SL; Ritter A
Drug Alcohol Rev; 2008 Sep; 27(5):504-8. PubMed ID: 18696297
[TBL] [Abstract][Full Text] [Related]
27. Association between mental health disorders, problem drug use, and regular prescription opioid use.
Sullivan MD; Edlund MJ; Zhang L; Unützer J; Wells KB
Arch Intern Med; 2006 Oct; 166(19):2087-93. PubMed ID: 17060538
[TBL] [Abstract][Full Text] [Related]
28. An estimation of the prevalence of opioid dependence in New Zealand.
Adamson SJ; Deering DE; Sellman JD; Sheridan J; Henderson C; Robertson R; Pooley S; Campbell SD; Frampton CM
Int J Drug Policy; 2012 Jan; 23(1):87-9. PubMed ID: 21696937
[TBL] [Abstract][Full Text] [Related]
29. Estimating the prevalence of opiates use by unlinked anonymous urine drug testing: a pilot study in Iran.
Nakhaee N; Divsalar K; Meimandi MS; Dabiri S
Subst Use Misuse; 2008; 43(3-4):513-20. PubMed ID: 18365947
[TBL] [Abstract][Full Text] [Related]
30. Comorbidity and temporal ordering of alcohol use disorders and other psychiatric disorders: results from a Danish register-based study.
Flensborg-Madsen T; Mortensen EL; Knop J; Becker U; Sher L; Grønbaek M
Compr Psychiatry; 2009; 50(4):307-14. PubMed ID: 19486728
[TBL] [Abstract][Full Text] [Related]
31. The AIDS epidemic in the city of Copenhagen, Denmark: potential years of life lost and impact on life expectancy.
Johansen JD; Smith E; Juel K; Rosdahl N
Scand J Public Health; 2005; 33(3):222-7. PubMed ID: 16040464
[TBL] [Abstract][Full Text] [Related]
32. Estimating high-risk cannabis and opiate use in Ankara, Istanbul and Izmir.
Kraus L; Hay G; Richardson C; Yargic I; Ilhan MN; Ay P; Karasahin F; Pinarci M; Tuncoglu T; Piontek D; Schulte B
Drug Alcohol Rev; 2017 Sep; 36(5):626-632. PubMed ID: 27349485
[TBL] [Abstract][Full Text] [Related]
33. Critical issues on opioids in chronic non-cancer pain: an epidemiological study.
Eriksen J; Sjøgren P; Bruera E; Ekholm O; Rasmussen NK
Pain; 2006 Nov; 125(1-2):172-9. PubMed ID: 16842922
[TBL] [Abstract][Full Text] [Related]
34. Estimating the prevalence of systemic sclerosis in the Lorraine region, France, by the capture-recapture method.
El Adssi H; Cirstea D; Virion JM; Guillemin F; de Korwin JD
Semin Arthritis Rheum; 2013 Apr; 42(5):530-8. PubMed ID: 23290691
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
[TBL] [Abstract][Full Text] [Related]
36. Use of capture-recapture to estimate the prevalence of opiate addiction in Barcelona, Spain, 1989.
Domingo-Salvany A; Hartnoll RL; Maguire A; Suelves JM; Antó JM
Am J Epidemiol; 1995 Mar; 141(6):567-74. PubMed ID: 7900724
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.
Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C
Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199
[TBL] [Abstract][Full Text] [Related]
38. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.
Birnbaum HG; White AG; Reynolds JL; Greenberg PE; Zhang M; Vallow S; Schein JR; Katz NP
Clin J Pain; 2006 Oct; 22(8):667-76. PubMed ID: 16988561
[TBL] [Abstract][Full Text] [Related]
39. The pattern of contact with general practice and casualty departments of immigrants and non-immigrants in Copenhagen, Denmark.
Dyhr L; Andersen JS; Engholm G
Dan Med Bull; 2007 Aug; 54(3):226-9. PubMed ID: 17850728
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of problematic cocaine consumption in a city of southern Europe, using capture-recapture with a single list.
Brugal MT; Domingo-Salvany A; Díaz de Quijano E; Torralba L
J Urban Health; 2004 Sep; 81(3):416-27. PubMed ID: 15273265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
